Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-43763
Wielinga, P Y; Löwenstein, C; Muff, S; Munz, M; Woods, S C; Lutz, T A (2010). Central amylin acts as an adiposity signal to control body weight and energy expenditure. Physiology & Behavior, 101(1):45-52.
- Registered users only
View at publisher
The pancreatic B-cell hormone amylin has been proposed to be both a satiation signal and an adiposity signal. The effects of peripheral amylin on energy balance are well investigated, but the effects of central amylin are less clear. We determined the effects of low doses of amylin administered into the 3rd cerebral ventricle (i3vt) on food intake, body weight and other indices of energy balance. Amylin (2 pmol/h) significantly lowered body weight compared to saline after 2 weeks of infusion, independent of whether prior body weight was decreased by fasting, increased by voluntary overfeeding or unmanipulated. A bolus injection of amylin (10 pmol, i3vt) increased energy expenditure and body temperature, whereas chronic i3vt amylin infusion had no effect on energy expenditure above that of control rats even though body temperature was increased. Chronic amylin also reduced RQ, implying a preferential oxidation of fat. Overall, the data provide new evidence that amylin is an adiposity signal that acts within the brain, and informing the brain about the status of peripheral energy stores.
1 download since deposited on 27 Jan 2011
0 downloads since 12 months
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Center for Integrative Human Physiology
05 Vetsuisse Faculty > Institute of Veterinary Physiology
|DDC:||570 Life sciences; biology
610 Medicine & health
|Deposited On:||27 Jan 2011 16:26|
|Last Modified:||27 Nov 2013 20:49|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page